Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (391-400 of 785) with videos related to

Pageof 79
Sort By:
BMC Nephrology|October 27, 2017
Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV surveyMartin Wagner, Christoph Wanner, Martin Schich, et al.
Orphanet Journal of Rare Diseases|July 7, 2026
Automated quantification of skin Gb3 load and white matter lesion assessment in Fabry diseaseCatharina Pfister, Magnus Schindehütte, Christoph Erbacher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2024
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial HypertensionPantelis Sarafidis, Roland Schmieder, Michel Burnier, et al.
Journal of Hypertension|April 19, 2005
Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loadingThomas Quaschning, Benjamin Rebhan, Christoph Wunderlich, et al.
ESC Heart Failure|December 29, 2023
Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular diseaseAbhinav Sharma, Silvio E Inzucchi, Jeffrey M Testani, et al.
Stroke|July 14, 2023
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome TrialsPriyadarshini Balasubramanian, Walter N Kernan, Kevin N Sheth, et al.
American Journal of Preventive Cardiology|June 29, 2023
Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteriaSubodh Verma, Andrew Kosmopoulos, Deepak L Bhatt, et al.
Journal of the American Heart Association|June 2, 2016
High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry DiseaseNora Seydelmann, Dan Liu, Johannes Krämer, et al.
Journal of Medical Genetics|October 23, 2015
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapyDavid G Warnock, Christie P Thomas, Bojan Vujkovac, et al.
Medicine|May 26, 2018
Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational studyDaniel Oder, Dan Liu, Nurcan Üçeyler, et al.
Pageof 79

Showing results (391-400 of 785) with videos related to

Sort By:
Pageof 79
BMC Nephrology|October 27, 2017
Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV surveyMartin Wagner, Christoph Wanner, Martin Schich, et al.
Orphanet Journal of Rare Diseases|July 7, 2026
Automated quantification of skin Gb3 load and white matter lesion assessment in Fabry diseaseCatharina Pfister, Magnus Schindehütte, Christoph Erbacher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2024
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial HypertensionPantelis Sarafidis, Roland Schmieder, Michel Burnier, et al.
Journal of Hypertension|April 19, 2005
Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loadingThomas Quaschning, Benjamin Rebhan, Christoph Wunderlich, et al.
ESC Heart Failure|December 29, 2023
Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular diseaseAbhinav Sharma, Silvio E Inzucchi, Jeffrey M Testani, et al.
Stroke|July 14, 2023
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome TrialsPriyadarshini Balasubramanian, Walter N Kernan, Kevin N Sheth, et al.
American Journal of Preventive Cardiology|June 29, 2023
Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteriaSubodh Verma, Andrew Kosmopoulos, Deepak L Bhatt, et al.
Journal of the American Heart Association|June 2, 2016
High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry DiseaseNora Seydelmann, Dan Liu, Johannes Krämer, et al.
Journal of Medical Genetics|October 23, 2015
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapyDavid G Warnock, Christie P Thomas, Bojan Vujkovac, et al.
Medicine|May 26, 2018
Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational studyDaniel Oder, Dan Liu, Nurcan Üçeyler, et al.
Pageof 79